LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2493 | 4156 | 0.5998 | 0.4306 |
MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1788 | 4156 | 0.4303 | 0.1893 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3561 | 4156 | 0.8569 | 0.7963 |
MCF7 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1528 | 4156 | 0.3678 | 0.1004 |
MCF7 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3339 | 4156 | 0.8035 | 0.7203 |
MCF7 | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3194 | 4156 | 0.7686 | 0.6707 |
MCF7 | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2047 | 4156 | 0.4927 | 0.2781 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 777 | 4156 | 0.1870 | -0.1568 |
MCF7 | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 592 | 4156 | 0.1426 | -0.2201 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3231 | 4156 | 0.7774 | 0.6833 |
MCF7 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3410 | 4156 | 0.8205 | 0.7445 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4829 | 4156 | 1.1619 | 1.2304 |
MCF7 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2485 | 4156 | 0.5979 | 0.4278 |
MCF7 | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3297 | 4156 | 0.7934 | 0.7061 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 906 | 4156 | 0.2182 | -0.1125 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 972 | 4156 | 0.2339 | -0.0902 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3010 | 4156 | 0.7242 | 0.6076 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4352 | 4156 | 1.0472 | 1.0672 |
MCF7 | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4342 | 4156 | 1.0447 | 1.0636 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1523 | 4156 | 0.3665 | 0.0986 |
MCF7 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3615 | 4156 | 0.8698 | 0.8147 |
MCF7 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1203 | 4156 | 0.2895 | -0.0111 |
MCF7 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4531 | 4156 | 1.0902 | 1.1283 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1395 | 4156 | 0.3357 | 0.0548 |
MCF7 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1321 | 4156 | 0.3178 | 0.0293 |